Surmodics

Biolase (NASDAQ: BIOL) Stock Quote

Last Trade: US$0.08 -0.0017 -2.18
Volume: 4,155,925
5-Day Change: -6.38%
YTD Change: -88.26%
Market Cap: US$2.390M

Latest News From Biolase

LAKE FOREST, Calif. , June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly-designated Series I Preferred Stock, par value $0.001 per share, for each outstanding share of BIOLASE common stock held of record as of 5:00 p.m. Eastern Time on June 16, 2023.... Read More
LAKE FOREST, Calif. , June 5, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers. The Company believes its revenue-generating strategies and prudent management of its expenses, combined with the completion of its recent equity offering to strengthen its... Read More
LAKE FOREST, Calif. , May 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of... Read More
LAKE FOREST, Calif. , May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $50.00 per share (the... Read More
Educational and Training Programs Introducing Broader Community of Dentists to Experience Industry-Leading Dental Lasers for the First Time LAKE FOREST, Calif. , May 11, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the first quarter ended March 31, 2023 . First Quarter Financial Highlights Reported revenue of $10.5 million , the ninth... Read More
LAKE FOREST, Calif. , May 4, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023 , after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments. To access the... Read More
LAKE FOREST, Calif. , March 28, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2022 . 2022 Full-Year Financial Highlights Achieved year-over-year revenue growth of 24% to $48.5 million Increased U.S. laser sales by 39% year over year Achieved record U.S. consumable sales, up 25% year over... Read More
Lab Session Will Provide Firsthand Experience using the Company's Award-Winning Waterlase All-Tissue Laser Annual Tequila & Tongue Ties Conference to be held in Scottsdale, AZ , on April 21-22, 2023 LAKE FOREST, Calif. , March 14, 2023 /PRNewswire/ -- BIOLASE, Inc . (NASDAQ: BIOL), the global leader in dental lasers, today announced plans to host its annual Tequila & Tongue Ties conference, a gathering of key opinion leaders... Read More
LAKE FOREST, Calif. , March 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full year 2022 financial and operating results on Tuesday, March 28, 2023 , after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate... Read More
New Episodes Will Feature Engaging Stories from Clinicians About the Benefits of Laser Technology in Dentistry LAKE FOREST, Calif. , March 6, 2023 /PRNewswire/ -- BIOLASE, Inc . (NASDAQ: BIOL), the global leader in dental lasers, today announced plans to launch a second season of the popular podcast series, "BIOLASE: Advancing Dentistry." Due to the overwhelmingly positive response from the dental community, the rising... Read More
LAKE FOREST, Calif. , Feb. 27, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers and a company continually focused on improving the dental ecosystem, has launched a new e-commerce website for its U.S. customers. The new website, store.biolase.com , combines a state-of-the-art desktop and mobile-friendly design with "collections" for a unique and modern shopping experience that customers... Read More
The new handpiece uses advanced, proprietary technology to deliver faster healing and quicker recovery for skin-resurfacing patients LAKE FOREST, Calif. , Feb. 23, 2023 /PRNewswire/ -- BIOLASE, Inc . (NASDAQ: BIOL), the global leader in dental lasers, announced today the U.S. launch of the Waterlase Fractional Handpiece for doctors seeking a faster and more efficient way to perform skin resurfacing. The Waterlase Fractional... Read More
Intuitive Education.Biolase.com Portal W ill Ensure Positive User Experience LAKE FOREST, Calif. , Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and educational initiatives with the launch of its new education web portal, Education.Biolase.com , which allows the Company to offer tailored education pathways... Read More
LAKE FOREST, Calif. , Feb. 16, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February 21–24, 2023. John Beaver , President and Chief Executive Officer, and Jennifer Bright , Chief Financial Officer, will present at the conference and host virtual... Read More
LAKE FOREST, Calif. , Feb. 9, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Inland News Group. This award is in addition to the Top Workplaces 2022 honor from the Orange County Register, which BIOLASE previously announced. The awards are based solely on employee feedback gathered through a... Read More
FOOTHILL RANCH, Calif. , Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by Sonendo, Inc., through its wholly-owned subsidiary PIPStek LLC (Sonendo), to use patent litigation to try to save Sonendo's diminished position and reputation in the marketplace. BIOLASE is well known for its own industry-leading... Read More
FOOTHILL RANCH, Calif. , Jan. 18, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between $14.0 million and $14.4 million , well above 2021 fourth quarter revenue of $12.4 million . The Company will report fourth quarter and full-year 2022 results in March 2023. As... Read More
LAKE FOREST, Calif. , Jan. 12, 2023 /PRNewswire/ -- BIOLASE , Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor by the Orange County Register Top Workplaces. The award is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner, Energage LLC. The confidential survey... Read More
LAKE FOREST, Calif. , Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre-funded warrant. The pre-funded... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB